Chapter 14
Antiepileptic Drugs
Phenobarbital
Classification: Barbiturate
Mechanism of Action: Enhances the activity of GABA, an inhibitory neurotransmitter, leading to increased neuronal inhibition.
Indication for Use: Primarily used for the management of seizures, particularly in status epilepticus and as a sedative.
Side Effects: Drowsiness, dizziness, respiratory depression, dependence, and withdrawal symptoms upon discontinuation.
Nursing Implications: Monitor respiratory function and sedation levels; assess for signs of dependence; educate on potential interactions with other CNS depressants.
Patient Teaching: Advise patients to avoid alcohol and other CNS depressants; inform about the risk of withdrawal symptoms; emphasize adherence to prescribed dosage.
Primidone
Classification: Anticonvulsant
Mechanism of Action: Metabolized into phenobarbital; enhances GABA activity and decreases excitatory neurotransmission.
Indication for Use: Used for the treatment of generalized tonic-clonic seizures and focal seizures.
Side Effects: Sedation, dizziness, ataxia, nausea, and potential for allergic reactions.
Nursing Implications: Monitor liver function tests; assess seizure frequency and severity; watch for signs of hypersensitivity reactions.
Patient Teaching: Instruct on the importance of regular blood tests to monitor drug levels; advise against abrupt discontinuation.
Hydantoins (Phenytoin)
Classification: Anticonvulsant
Mechanism of Action: Stabilizes neuronal membranes by inhibiting sodium channels during depolarization.
Indication for Use: Effective in controlling tonic-clonic seizures and partial seizures.
Side Effects: Gingival hyperplasia, rash, ataxia, drowsiness, and potential cardiovascular effects with rapid infusion.
Nursing Implications: Monitor serum drug levels to prevent toxicity; assess oral hygiene due to gingival hyperplasia risk; observe for skin rashes that may indicate Stevens-Johnson syndrome.
Patient Teaching: Educate on maintaining good dental hygiene; inform about potential side effects like dizziness or rash; stress adherence to medication schedule.
Fosphenytoin
Classification: Anticonvulsant (prodrug of phenytoin)
Mechanism of Action: Similar to phenytoin but is more water-soluble allowing for intravenous administration without irritation.
Indication for Use: Used in acute seizure management (e.g., status epilepticus).
Side Effects: Paresthesia, pruritus, hypotension with rapid infusion, and dizziness.
Nursing Implications: Administer slowly IV to prevent hypotension; monitor cardiac rhythm during administration; check serum phenytoin levels post-infusion.
Patient Teaching: Explain the purpose of IV administration in emergencies; advise on possible side effects like tingling or itching.
Carbamazepine
Classification: Anticonvulsant
Mechanism of Action: Inhibits sodium channels which stabilizes hyperexcited neural membranes.
Indication for Use: Effective in treating partial seizures and trigeminal neuralgia. Also used in bipolar disorder management.
Side Effects: Dizziness, drowsiness, nausea, leukopenia, and risk of serious skin reactions (Stevens-Johnson syndrome).
Nursing Implications: Monitor complete blood counts regularly; assess liver function tests due to potential hepatotoxicity; educate about signs of severe skin reactions.
Patient Teaching: Inform about the need for regular blood tests; advise against abrupt cessation due to withdrawal risks.
Oxcarbazepine
Classification: Anticonvulsant
Mechanism of Action: Blocks voltage-sensitive sodium channels similar to carbamazepine but has fewer side effects related to enzyme induction.
Indication for Use: Used primarily as adjunctive therapy in partial seizures in adults and children over 2 years old.
Side Effects: Dizziness, somnolence, headache, nausea, hyponatremia (low sodium levels).
Nursing Implications: Monitor sodium levels periodically due to risk of hyponatremia; assess seizure control effectiveness regularly.
Patient Teaching: Educate on recognizing signs of low sodium (confusion or weakness); inform about possible interactions with other medications.
Succinimide (Ethosuximide)
Classification: Anticonvulsant
Mechanism of Action: Reduces calcium influx through T-type calcium channels in thalamic neurons which helps control absence seizures.
Indication for Use: Specifically indicated for absence seizures (petit mal).
Side Effects: Nausea, vomiting, lethargy, headache, and potential hematologic abnormalities such as leukopenia or aplastic anemia.
Nursing Implications: Monitor complete blood counts regularly; assess seizure frequency before and after treatment initiation.
Patient Teaching: Advise patients regarding possible gastrointestinal upset initially but that it often resolves over time.
Miscellaneous Drugs
gabapentin
Classification of Drug:
Gabapentin is classified as an anticonvulsant or antiepileptic medication. It is also categorized as a neuropathic pain agent.
Mechanism of Action:
Gabapentin primarily works by inhibiting the release of excitatory neurotransmitters through binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action reduces neuronal excitability and helps to stabilize electrical activity in the brain, which is beneficial for controlling seizures and alleviating neuropathic pain.
Indications for Use:
Gabapentin is indicated for:
Management of partial seizures in adults and children aged three years and older.
Treatment of postherpetic neuralgia (nerve pain following shingles).
Off-label uses include treatment for various types of neuropathic pain, restless legs syndrome, anxiety disorders, and migraine prophylaxis.
Side Effects:
Common side effects include:
Drowsiness
Dizziness
Fatigue
Ataxia (loss of coordination)
Peripheral edema (swelling in extremities)
Serious side effects may include:
Allergic reactions (e.g., rash, itching)
Mood changes or depression
Suicidal thoughts or behavior
Respiratory depression, especially when combined with other CNS depressants
Nursing Implications:
Nurses should monitor patients for:
Efficacy in seizure control or pain relief.
Side effects, particularly sedation and dizziness.
Signs of mood changes or suicidal ideation.
Educate patients about:
The importance of adhering to prescribed dosages.
Avoiding abrupt discontinuation to prevent withdrawal symptoms.
Potential interactions with other medications, particularly those that depress the central nervous system.
Assess renal function prior to initiation and during therapy since gabapentin is primarily excreted unchanged by the kidneys; dosage adjustments may be necessary in patients with renal impairment.
Lamotrigine
Classification of drug: Anticonvulsant, mood stabilizer
Mechanism of action: Blocks sodium channels, inhibits glutamate release, and increases GABA activity
Indication for use: Treatment of partial seizures, generalized seizures, and bipolar disorder
Side effects: Dizziness, headache, nausea, vomiting, rash, and rare but serious side effects such as Stevens-Johnson syndrome and toxic epidermal necrolysis
Nursing implications: Monitor patient for signs of rash, monitor liver function and blood counts, and educate patient on proper administration and potential side effects
Patient teaching: Take medication as directed, do not stop taking medication without consulting doctor, and report any signs of rash or other side effects to doctor immediately
Pharmacology and Mechanism of Action
Lamotrigine works by blocking sodium channels, which helps to reduce the excitability of neurons and prevent seizures. It also inhibits the release of glutamate, an excitatory neurotransmitter, and increases the activity of GABA, an inhibitory neurotransmitter.
Indications and Contraindications
Lamotrigine is indicated for the treatment of partial seizures, generalized seizures, and bipolar disorder. It is not recommended for patients with a history of hypersensitivity to lamotrigine or other anticonvulsants.
Nursing Implications and Patient Teaching
Nurses should monitor patients taking lamotrigine for signs of rash and other side effects, and educate patients on proper administration and potential side effects. Patients should be instructed to take the medication as directed, not to stop taking the medication without consulting their doctor, and to report any signs of rash or other side effects to their doctor immediately.
levetiracetam
Classification of Drug:
Levetiracetam is classified as an anticonvulsant or antiepileptic medication. It is commonly used to treat seizures in individuals with epilepsy.
Mechanism of Action:
The exact mechanism of action of levetiracetam is not fully understood. However, it is believed to work by binding to the synaptic vesicle protein 2A (SV2A), which modulates neurotransmitter release and inhibits excessive neuronal firing. This action helps stabilize electrical activity in the brain and reduces the frequency of seizures.
Indication for Use:
Levetiracetam is indicated for:
The treatment of partial-onset seizures in adults and children aged 1 month and older.
Myoclonic seizures in patients with juvenile myoclonic epilepsy.
Primary generalized tonic-clonic seizures in adults and children aged 6 years and older.
Side Effects:
Common side effects include:
Drowsiness
Fatigue
Dizziness
Irritability
Loss of appetite
Nausea
Serious side effects may include:
Mood changes, including depression or suicidal thoughts
Severe allergic reactions (e.g., rash, itching, swelling)
Blood disorders (e.g., low blood cell counts)
Nursing Implications:
Monitor the patient for signs of seizure activity and assess the effectiveness of the medication.
Evaluate for potential side effects, particularly mood changes or behavioral issues.
Ensure proper dosing schedule adherence; educate patients about not abruptly discontinuing the medication to avoid withdrawal seizures.
Assess renal function prior to initiation and periodically during therapy, as dosage adjustments may be necessary in patients with renal impairment.
Patient Teaching:
Instruct patients to take levetiracetam exactly as prescribed, without skipping doses.
Advise on potential side effects and when to seek medical attention (e.g., severe mood changes).
Educate about the importance of maintaining a consistent dosing schedule and not stopping the medication suddenly.
Discuss lifestyle modifications that may help manage epilepsy, such as avoiding triggers for seizures (e.g., lack of sleep, alcohol consumption).
pregabalin
Classification of Drug:
Pregabalin is classified as an anticonvulsant and neuropathic pain agent. It is also categorized under the class of drugs known as gabapentinoids.
Mechanism of Action:
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding inhibits excitatory neurotransmitter release, which reduces neuronal excitability and helps alleviate pain and seizures. By modulating calcium influx at nerve terminals, it decreases the release of several neurotransmitters including glutamate, norepinephrine, and substance P.
Indication for Use:
Pregabalin is indicated for:
Management of neuropathic pain associated with diabetic peripheral neuropathy.
Treatment of postherpetic neuralgia.
Adjunctive therapy for adults with partial onset seizures.
Management of generalized anxiety disorder (GAD).
Treatment of fibromyalgia.
Side Effects:
Common side effects include:
Dizziness
Drowsiness
Dry mouth
Edema (swelling)
Weight gain
Blurred vision
Serious side effects may include:
Allergic reactions (e.g., rash, itching)
Mood changes (e.g., depression, suicidal thoughts)
Difficulty breathing or swallowing
Severe dizziness or fainting
Nursing Implications:
Monitor patients for signs of sedation and dizziness, especially when initiating therapy or increasing doses.
Assess renal function prior to starting treatment since dosage adjustments may be necessary in patients with renal impairment.
Evaluate for any history of substance abuse as pregabalin has potential for misuse.
Educate patients about the risk of withdrawal symptoms if discontinuation occurs abruptly after long-term use.
Patient Teaching:
Instruct patients to take pregabalin exactly as prescribed and not to exceed the recommended dose.
Advise patients to avoid alcohol and other CNS depressants while taking this medication due to increased risk of sedation.
Inform patients about potential side effects and advise them to report any severe or unusual symptoms immediately.
Encourage adherence to follow-up appointments for monitoring effectiveness and side effects.
tiagabine
Classification of Drug:
Tiagabine is classified as an anticonvulsant and is specifically categorized as a GABA reuptake inhibitor.
Mechanism of Action:
Tiagabine works by inhibiting the reuptake of gamma-aminobutyric acid (GABA) in the brain. By preventing the reabsorption of GABA, tiagabine increases the concentration of this inhibitory neurotransmitter in the synaptic cleft, enhancing its effects. This action helps to stabilize neuronal excitability and reduce seizure activity.
Indication for Use:
Tiagabine is primarily indicated for the treatment of partial seizures in patients with epilepsy. It may be used as an adjunctive therapy in conjunction with other antiepileptic medications to help control seizures that are not adequately managed by monotherapy.
Side Effects:
Common side effects associated with tiagabine include:
Dizziness
Fatigue
Somnolence (drowsiness)
Nausea
Tremor
Nervousness
Difficulty concentrating
Serious side effects may include:
Seizures (in patients without epilepsy)
Depression or mood changes
Allergic reactions such as rash or swelling
Nursing Implications:
Nurses should monitor patients for signs of seizure activity, especially during dosage adjustments.
Assess mental status regularly, noting any changes in mood or behavior.
Evaluate for potential drug interactions, particularly with other CNS depressants.
Ensure that patients are educated about the importance of adherence to prescribed therapy and not abruptly discontinuing tiagabine, as this can lead to increased seizure frequency.
Patient Teaching:
Instruct patients to take tiagabine exactly as prescribed and not to skip doses.
Advise them about possible side effects and when to seek medical attention (e.g., worsening mood changes or unusual behavior).
Educate on avoiding alcohol and other CNS depressants while taking this medication due to increased risk of sedation.
Encourage patients to keep a seizure diary to track their seizure frequency and any potential triggers.
topiramate
Introduction to Topiramate
Topiramate is a medication that is used to treat various conditions, including epilepsy, migraines, and obesity.
Classification of Drug
The classification of topiramate is as an anticonvulsant or antiepileptic drug, which is also used for its neuroprotective, anti-migraine, and weight loss properties.
Mechanism of Action
The mechanism of action of topiramate involves blocking voltage-dependent sodium channels, augmenting the activity of gamma-aminobutyric acid (GABA) at GABA_A receptors, antagonizing the AMPA/kainate subtype of the glutamate receptor, and inhibiting carbonic anhydrase.
Indication for Use
The indications for use of topiramate include:
Epilepsy: for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome
Migraines: for the prophylaxis of migraines
Obesity: as an adjunct to diet and exercise for weight loss in obese adults
Side Effects
The side effects of topiramate include:
Cognitive impairment
Dizziness
Fatigue
Nausea
Renal stones
Weight loss
Nursing Implications
The nursing implications for topiramate include:
Monitoring for signs of cognitive impairment, such as confusion and memory loss
Monitoring for signs of renal stones, such as flank pain and hematuria
Encouraging patients to drink plenty of water to reduce the risk of renal stones
Monitoring for signs of weight loss, such as decreased appetite and weight
Patient Teaching
The patient teaching for topiramate includes:
Taking the medication as directed
Reporting any signs of cognitive impairment, such as confusion and memory loss
Reporting any signs of renal stones, such as flank pain and hematuria
Drinking plenty of water to reduce the risk of renal stones
Monitoring weight and reporting any significant weight loss
valproic acid
Valproic Acid Overview
Classification of Drug:
Valproic acid is classified as an anticonvulsant and mood-stabilizing agent. It is also categorized under the chemical class of fatty acid derivatives.
Mechanism of Action:
The precise mechanism of action of valproic acid is not fully understood, but it is believed to involve several pathways:
Inhibition of voltage-gated sodium channels, which stabilizes neuronal membranes and reduces excitability.
Enhancement of gamma-aminobutyric acid (GABA) levels in the brain, a neurotransmitter that has inhibitory effects on neuronal activity.
Modulation of glutamate signaling, which may contribute to its anticonvulsant effects.
Indication for Use:
Valproic acid is indicated for:
Treatment of various types of seizures, including generalized tonic-clonic seizures, absence seizures, and partial seizures.
Management of bipolar disorder to stabilize mood and prevent manic episodes.
Prevention of migraine headaches.
Side Effects:
Common side effects include:
Gastrointestinal disturbances (nausea, vomiting, diarrhea).
Central nervous system effects (drowsiness, dizziness, tremors).
Weight gain.
Hair loss.
Serious side effects may include:
Hepatotoxicity (liver damage), particularly in young children or those with pre-existing liver conditions.
Pancreatitis (inflammation of the pancreas).
Teratogenic effects if taken during pregnancy (risk of neural tube defects).
Nursing Implications:
Monitor liver function tests regularly due to the risk of hepatotoxicity.
Assess for signs and symptoms of pancreatitis (abdominal pain, nausea/vomiting).
Evaluate therapeutic drug levels to ensure they are within the recommended range (50-100 µg/mL for seizure control).
Be aware of potential drug interactions with other medications that may affect valproic acid metabolism.
Patient Teaching:
Instruct patients to take valproic acid exactly as prescribed and not to discontinue abruptly without consulting a healthcare provider.
Advise patients about the importance of regular blood tests to monitor liver function and drug levels.
Educate about potential side effects and when to seek medical attention (e.g., signs of liver dysfunction like jaundice or abdominal pain).
Discuss the risks associated with pregnancy and the need for effective contraception while taking this medication.
zonisamide
Zonisamide Overview
Classification of Drug:
Zonisamide is classified as an anticonvulsant or antiepileptic medication. It falls under the category of sulfonamides and is used primarily for the management of seizures.
Mechanism of Action:
Zonisamide works by stabilizing neuronal membranes and inhibiting repetitive neuronal firing. It does this through several mechanisms:
Inhibition of voltage-gated sodium channels, which reduces the excitability of neurons.
Modulation of T-type calcium channels, which decreases calcium influx into neurons, further contributing to its anticonvulsant effects.
Enhancement of GABA (gamma-aminobutyric acid) activity, a neurotransmitter that inhibits neuronal excitability.
Indication for Use:
Zonisamide is indicated for:
The treatment of partial seizures in adults and children aged 16 years and older with epilepsy.
It may also be used as an adjunctive therapy for generalized seizures and has been studied for other conditions such as Parkinson’s disease and weight loss.
Side Effects:
Common side effects include:
Drowsiness
Dizziness
Fatigue
Nausea
Anorexia
Serious side effects may include:
Severe skin reactions (e.g., Stevens-Johnson syndrome)
Metabolic acidosis
Kidney stones (nephrolithiasis)
Blood dyscrasias (e.g., leukopenia, thrombocytopenia)
Nursing Implications:
Monitor patients for signs of allergic reactions or severe skin rashes.
Assess renal function prior to initiation due to the risk of kidney stones.
Evaluate electrolyte levels periodically, especially bicarbonate levels due to the potential for metabolic acidosis.
Educate patients about the importance of adherence to prescribed therapy and not abruptly discontinuing the medication.
Patient Teaching:
Instruct patients on how to take zonisamide (with or without food).
Advise patients to stay hydrated to reduce the risk of kidney stones.
Inform patients about possible side effects and when to seek medical attention (e.g., rash, difficulty breathing).
Encourage patients to avoid alcohol and other CNS depressants while taking zonisamide.